Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study

• by William Daniel Soulsby, John Boscardin, Andrea Knight, Daniel B. Horton, Karine Toupin-April, Emily von Scheven

• April 30, 2026

Leukemia Case Prompts Broader Review

Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.

• by Kathryn Wighton

• February 12, 2026

• 4 min

Case report: The masquerading spectrum: a pediatric case series of IgG4-related disease

• by Olga Viktorovna Shpitonkova, Natalia Anatolievna Geppe, Vera Alekseevna Podzolkova, Elena Yurievna Afonina, Tatiana Vladimirovna Zubareva, Maria Nikolaevna Nikolaeva, Natalia Yurievna Golovanova, Maria Kirillovna Osminina, Elena Vasilievna Frolkova, Maria Alekseevna Kudryashova, Nadezhda Stepanovna Podchernyaeva

• May 8, 2026

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

• by Kathryn Wighton

• June 29, 2026

• 3 min